Director/PDMR Shareholding

RNS Number : 2747R
Polypipe Group PLC
26 June 2020
 

Polypipe Group plc (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities

The Company announces that on 26 June 2020, Martin Payne, Chief Executive Officer and a Person Discharging Managerial Responsibilities, acquired 651 Shares in lieu of dividends payable, following the exercise of the Awards granted to him on 25 April 2017 and 2 May 2018 under the Deferred Share Bonus Plan, details of which were announced on 18 June 2020. 

The Company also announces that on 26 June 2020, Glen Sabin, Chief Operating Officer and a Person Discharging Managerial Responsibilities, acquired 57 Shares in lieu of dividends payable, following the exercise of the Award granted to him on 2 May 2018 under the Deferred Share Bonus Plan, details of which were also announced on 18 June 2020. 

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Martin Payne

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer/Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polypipe Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Polypipe Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of Shares in lieu of dividends for no consideration pursuant to the exercise of nil-cost options as follows:

Deferred Share Bonus Plan award granted on 25 April 2017 (" 2017 DSBP")

Deferred Share Bonus Plan award granted on 2 May 2018 ("2018 DSBP")

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

351 - Number of 2017 DSBP Shares acquired having satisfied appropriate tax and national insurance liabilities.

 

300 - Number of 2018 DSBP Shares acquired having satisfied appropriate tax and national insurance liabilities.

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

26 June 2020

f)

 

Place of the transaction

 

 

Outside a trading venue  

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Glen Sabin

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Operating Officer/Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polypipe Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Polypipe Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of Shares in lieu of dividends for no consideration pursuant to the exercise of nil-cost options as follows:

Deferred Share Bonus Plan ("DSBP") award granted on 2 May 2018

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

57 - Number of DSBP Shares acquired having satisfied appropriate tax and national insurance liabilities.

 

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

26 June 2020

f)

 

Place of the transaction

 

 

Outside a trading venue

 

Enquiries:

Emma Versluys, Company Secretary

+44 (0) 1709 770 000

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKKABDPBKDFAB

Companies

Genuit Group (GEN)
UK 100

Latest directors dealings